pembrolizumab和阿西替尼联合治疗伴有慢性肾病的肾细胞癌的疗效

{"title":"pembrolizumab和阿西替尼联合治疗伴有慢性肾病的肾细胞癌的疗效","authors":"T.N. Trofimtseva Trofimtseva, S.K. Yarovoy Yarovoy, A.A. Gritskevich Gritskevich, T.P. Baytman Baytman","doi":"10.18565/pharmateca.2023.11.31-36","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20153,"journal":{"name":"Pharmateca","volume":"31 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of the combination of pembrolizumab and axitinib in the treatment of renal cell carcinoma associated with chronic kidney disease\",\"authors\":\"T.N. Trofimtseva Trofimtseva, S.K. Yarovoy Yarovoy, A.A. Gritskevich Gritskevich, T.P. Baytman Baytman\",\"doi\":\"10.18565/pharmateca.2023.11.31-36\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20153,\"journal\":{\"name\":\"Pharmateca\",\"volume\":\"31 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmateca\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18565/pharmateca.2023.11.31-36\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmateca","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18565/pharmateca.2023.11.31-36","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}